Hypophosphatemia after high-dose intravenous iron treatment in patients with inflammatory bowel disease: Mechanisms and possible clinical impact

BACKGROUND: High-dose intravenous iron is an effective treatment option for iron deficiency (ID) or ID anaemia (IDA) in inflammatory bowel disease (IBD). However, treatment with ferric carboxymaltose (FCM) has been associated with the development of hypophosphatemia. AIM: To investigate mechanisms b...

Descripción completa

Detalles Bibliográficos
Autores principales: Detlie, Trond Espen, Lindstrøm, Jonas Christoffer, Jahnsen, Marte Eide, Finnes, Elisabeth, Zoller, Heinz, Moum, Bjørn, Jahnsen, Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108035/
https://www.ncbi.nlm.nih.gov/pubmed/34007138
http://dx.doi.org/10.3748/wjg.v27.i17.2039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108035/
https://www.ncbi.nlm.nih.gov/pubmed/34007138
http://dx.doi.org/10.3748/wjg.v27.i17.2039

Ejemplares similares